Document Detail

Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
MedLine Citation:
PMID:  10492127     Owner:  NLM     Status:  MEDLINE    
Although it is known that a caloric liquid meal given after food intake delays solid gastric emptying, the effect of a noncaloric liquid is not known. The aims of this study were to determine the effect of normal saline given at 3 hr after feeding on gastric antral motor activity and gastric emptying and to evaluate the role of endogenous cholecystokinin in the changes in gastric function induced by postprandial saline intake in conscious dogs. Two cannulas were implanted in each of five mongrel dogs for infusion of phenolsulfonphthalein into the proximal duodenum and for aspiration of luminal samples from the distal duodenum. Gastric contractile and emptying activity were measured by the force transducer method and a freeze-drying method newly developed by our group, respectively. Postprandial pancreaticobiliary secretion was assessed from amylase and bile acid outputs into the duodenum. One hundred grams of freeze-dried dog food was given as a solid meal after mixing it with 100 ml of normal saline. The dogs were given 100 ml of normal saline per os at 3 hr after feeding. In another study, intravenous administration of devazepide, a specific cholecystokinin-A receptor antagonist, at a dose of 0.1 mg/kg/hr was begun 15 min before postprandial saline intake and continued for 1 hr. Gastric antral motility was significantly (P < 0.01) inhibited for 30 min after the dogs had drunk saline at 3 hr after feeding. The mean fractional emptying rate of gastric solids in percentage per 30 min after postprandial saline intake was significantly (P < 0.05) slower than that in the control study without saline intake at 3 hr after feeding. Amylase output into the duodenum after postprandial saline intake showed a gradual increase lasting for about 1 hr, whereas that of bile acid increased transiently but markedly 15 min after saline intake, in comparison with the control study. Pretreatment with devazepide partially ameliorated the suppression of gastric antral motility. Postprandial intake of saline inhibited gastric motor activity and delayed solid gastric emptying, whereas it increased the outputs of amylase and bile acid. Endogenous cholecystokinin may be partially involved in these phenomena caused by saline intake at 3 hr after feeding.
T Tanaka; A Mizumoto; S Muramatsu; E Mochiki; N Haga; H Suzuki; Z Itoh
Related Documents :
17030967 - Physiological evidence for the involvement of peptide yy in the regulation of energy ho...
9036757 - Effect of a single high-fat meal on endothelial function in healthy subjects.
14525677 - Dietary fat and postprandial lipids.
3532757 - Thermic effect of medium-chain and long-chain triglycerides in man.
3559397 - Effects of synthetic glycosides on steroid balance in macaca fascicularis.
1745107 - Preferential loss of body fat during starvation in dietary obese rats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  44     ISSN:  0163-2116     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-09-28     Completed Date:  1999-09-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1516-24     Citation Subset:  AIM; IM    
Gastrointestinal Research Laboratory, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Animal Feed*
Bile Acids and Salts / secretion
Cholecystokinin / physiology
Devazepide / pharmacology
Eating / physiology*
Gastric Emptying / drug effects*,  physiology
Gastrointestinal Motility / drug effects
Hormone Antagonists / pharmacology
Pancreas / drug effects,  secretion
Receptor, Cholecystokinin A
Receptors, Cholecystokinin / antagonists & inhibitors
Reference Values
Sodium Chloride / metabolism,  pharmacology*
Reg. No./Substance:
0/Bile Acids and Salts; 0/Hormone Antagonists; 0/Receptor, Cholecystokinin A; 0/Receptors, Cholecystokinin; 103420-77-5/Devazepide; 7647-14-5/Sodium Chloride; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gastric emptying in spinal cord injury patients.
Next Document:  Molecular basis of altered contractility in experimental colitis: expression of L-type calcium chann...